| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Department of Medicine, Stony Brook University, Stony Brook, New York; 2 Veterans Affairs Medical Center, Northport, New York; and 3 Dipartimento di Biologia Cellulare e dello Sviluppo, Università di Palermo, Viale delle Scienze, Palermo, Italy
Requests for reprints: Wen-Tien Chen, Department of Medicine, HSC T15, Stony Brook University, Room 053, Stony Brook, NY 11794-8151. Phone: 631-444-6948; Fax: 631-444-7530; E-mail: wenchen{at}notes.cc.sunysb.edu.
Dipeptidyl peptidase IV (DPP4/CD26) and seprase/fibroblast activation protein
are homologous type II transmembrane, homodimeric glycoproteins that exhibit unique prolyl peptidase activities. Human DPP4 is ubiquitously expressed in epithelial and endothelial cells and serves multiple functions in cleaving the penultimate positioned prolyl bonds at the NH2 terminus of a variety of physiologically important peptides in the circulation. Recent studies showed a linkage between DPP4 and down-regulation of certain chemokines and mitogenic growth factors, and degradation of denatured collagens (gelatin), suggesting a role of DPP4 in the cell invasive phenotype. Here, we found the existence of a novel protease complex consisting of DPP4 and seprase in human endothelial cells that were activated to migrate and invade in the extracellular matrix in vitro. DPP4 and seprase were coexpressed with the three major protease systems (matrix metalloproteinase, plasminogen activator, and type II transmembrane serine protease) at the cell surface and organize as a complex at invadopodia-like protrusions. Both proteases were colocalized at the endothelial cells of capillaries, but not large blood vessels, in invasive breast ductal carcinoma in vivo. Importantly, monoclonal antibodies against the gelatin-binding domain of DPP4 blocked the local gelatin degradation by endothelial cells in the presence of the major metallo- and serine protease systems that modified pericellular collagenous matrices and subsequent cell migration and invasion. Thus, we have identified a novel mechanism involving the DPP4 gelatin-binding domain of the DPP4-seprase complex that facilitates the local degradation of the extracellular matrix and the invasion of the endothelial cells into collagenous matrices. (Cancer Res 2006; 66(9); 4652-61)
This article has been cited by other articles:
![]() |
N. B. Prasad, H. Somervell, R. P. Tufano, A. P.B. Dackiw, M. R. Marohn, J. A. Califano, Y. Wang, W. H. Westra, D. P. Clark, C. B. Umbricht, et al. Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors Clin. Cancer Res., June 1, 2008; 14(11): 3327 - 3337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |